| P2093 | author name string | Sheng-Quan Zhang | |
| | Lei Li | |
| | Fang Wang | |
| | Xin Luo | |
| | Bo Jia | |
| | Feng-Wei Cheng | |
| P2860 | cites work | Human TLR7 or TLR8 independently confer responsiveness to the antiviral compound R-848 | Q24298297 |
| | Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8 | Q24310398 |
| | Generation of secretable and nonsecretable interleukin 15 isoforms through alternate usage of signal peptides | Q24647708 |
| | A human homologue of the Drosophila Toll protein signals activation of adaptive immunity | Q28131769 |
| | Imiquimod applied topically: a novel immune response modifier and new class of drug | Q28140002 |
| | Interleukin 15 as a promising candidate for tumor immunotherapy | Q28236508 |
| | Review Article Imiquimod applied topically: a novel immune response modifier and new class of drug | Q29396548 |
| | Human papillomavirus is a necessary cause of invasive cervical cancer worldwide | Q29617514 |
| | Cloning and characterization of a sub-family of human toll-like receptors: hTLR7, hTLR8 and hTLR9. | Q33920505 |
| | Toll-like receptor 4 signaling in liver injury and hepatic fibrogenesis | Q34321742 |
| | Cytotoxic T lymphocytes: all roads lead to death | Q34716318 |
| | Tumour growth inhibition by an imidazoquinoline is associated with c-Myc down-regulation in urothelial cell carcinoma | Q34744159 |
| | Host innate immune receptors and beyond: making sense of microbial infections | Q34785533 |
| | Imiquimod and the imidazoquinolones: mechanism of action and therapeutic potential | Q35015851 |
| | Overexpression of TLR3, TLR4, TLR7 and TLR9 in esophageal squamous cell carcinoma | Q35235996 |
| | Toll-like receptors, inflammation and cancer | Q36254028 |
| | Toll-like receptor 7 regulates pancreatic carcinogenesis in mice and humans | Q36357873 |
| | Toll-like receptor agonists in the treatment of chronic lymphocytic leukemia | Q36635059 |
| | Toll-like receptors: key activators of leucocytes and regulator of haematopoiesis. | Q36952605 |
| | TLR signaling by tumor and immune cells: a double-edged sword | Q37051027 |
| | The use of TLR7 and TLR8 ligands for the enhancement of cancer immunotherapy | Q37243188 |
| | Papillomaviruses in the causation of human cancers - a brief historical account | Q37365856 |
| | The TLR7 agonists imiquimod and gardiquimod improve DC-based immunotherapy for melanoma in mice | Q37728656 |
| | Important aspects of Toll-like receptors, ligands and their signaling pathways | Q37769153 |
| | The role of interleukin-6 in gynaecological malignancies. | Q38048977 |
| | Role of phosphoinositide 3-kinase in activation of ras and mitogen-activated protein kinase by epidermal growth factor | Q39551502 |
| | Osteopontin promotes hepatocellular carcinoma invasion by up-regulating MMP-2 and uPA expression | Q39628244 |
| | Impaired expression and function of toll-like receptor 7 in hepatitis C virus infection in human hepatoma cells | Q39788612 |
| | PTEN regulates angiogenesis through PI3K/Akt/VEGF signaling pathway in human pancreatic cancer cells | Q39852386 |
| | Toll-like receptor 7 and MyD88 knockdown by lentivirus-mediated RNA interference to porcine dendritic cell subsets. | Q40165149 |
| | Tumor-selective induction of apoptosis and the small-molecule immune response modifier imiquimod | Q42445719 |
| | Hepatocyte growth factor protects endothelial progenitor cell from damage of low-density lipoprotein cholesterol via the PI3K/Akt signaling pathway | Q43291021 |
| | Toll-like receptor-7 tolerizes malignant B cells and enhances killing by cytotoxic agents | Q43881315 |
| | Tissue-specific mRNA expression profiles of human toll-like receptors and related genes | Q44407781 |
| | MMP-2 and TIMP-1 are derived from, not in response to, pancreatic cancer | Q45882622 |
| | Type IV collagenase (matrix metalloproteinase-2 and -9) in prostate cancer. | Q54702586 |
| | Association between Toll-Like Receptor Gene Cluster (TLR6, TLR1, and TLR10) and Prostate Cancer | Q58033496 |
| | Imbalance of expression of matrix metalloproteinases (MMPs) and tissue inhibitors of the matrix metalloproteinases (TIMPs) in human pancreatic carcinoma | Q73828612 |
| | Amentoflavone inhibits experimental tumor metastasis through a regulatory mechanism involving MMP-2, MMP-9, prolyl hydroxylase, lysyl oxidase, VEGF, ERK-1, ERK-2, STAT-1, NM23 and cytokines in lung tissues of C57BL/6 mice | Q81753761 |
| | Regulation of Toll-like receptor-induced chemokine production in murine dendritic cells by mitogen-activated protein kinases | Q84184149 |
| P433 | issue | 1-2 | |
| P921 | main subject | toll-like receptor | Q408004 |
| P304 | page(s) | 43-49 | |
| P577 | publication date | 2013-12-18 | |
| P1433 | published in | Molecular and Cellular Biochemistry | Q1573176 |
| P1476 | title | The activation of TLR7 regulates the expression of VEGF, TIMP1, MMP2, IL-6, and IL-15 in Hela cells | |
| P478 | volume | 389 | |